Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 12.45
0.484 %
$ 1.64 B
Market Cap
83.0
P/E
DVAX - REVENUE
Revenue DVAX - Dynavax Technologies Corporation
232 M
LAST VALUE
-27.30%
2 YEAR CAGR
95.19%
5 YEAR CAGR
35.36%
10 YEAR CAGR